Epigenetic Landscape of DNA Methylation in Pancreatic Ductal Adenocarcinoma

Epigenetic Landscape of DNA Methylation in Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies, characterized by its aggressive progression and dismal prognosis. Advances in epigenetic profiling, specifically DNA methylation analysis, have significantly deepened our understanding of PDAC pathogenesis. This rev...

Full description

Saved in:

Bibliographic Details
Main Authors:	Peiyi Liu, Juliette Jacques, Chang-Il Hwang
Format:	Article
Language:	English
Published:	MDPI AG 2024-11-01
Series:	Epigenomes
Subjects:	DNA methylation pancreatic ductal adenocarcinoma pancreatic cancer whole-genome bisulfite sequencing metastasis
Online Access:	https://www.mdpi.com/2075-4655/8/4/41
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Epigenetic evolution and clinicopathological implications of distinct DNA methylation profiles in pancreatic ductal adenocarcinoma
by: Keiichiro Kitahama, et al.
Published: (2025-08-01)

Pancreatic ductal adenocarcinoma arising from the pancreatic parenchyma compressed by a huge pancreatic lipoma: a case report
by: Seiji Nakahara, et al.
Published: (2023-08-01)

Cancer stem cells and mesenchymal stem cells in pancreatic ductal adenocarcinoma
by: V. O. Tumanskyi, et al.
Published: (2019-06-01)

Circulating cell‐free DNA methylation‐based multi‐omics analysis allows early diagnosis of pancreatic ductal adenocarcinoma
by: Guochao Zhao, et al.
Published: (2024-11-01)

Does acute pancreatitis herald pancreatic ductal adenocarcinoma? A multicenter electronic health research network study
by: Ritu R. Singh, et al.
Published: (2023-02-01)

Contribution of gut microbiome to pancreatic ductal adenocarcinoma development
by: D. V. Zaitsev, et al.
Published: (2025-05-01)

Long-term survival after hepatectomy for metachronous liver metastasis of pancreatic ductal adenocarcinoma: a case report
by: Chikanori Tsutsumi, et al.
Published: (2020-07-01)

Immunohistochemical Evaluation of the Tumor Immune Microenvironment in Pancreatic Ductal Adenocarcinoma
by: Gelu Mihai Breaza, et al.
Published: (2025-03-01)

Promoter hypermethylation of SFRP1 is an allele fraction-dependent prognostic biomarker in metastatic pancreatic ductal adenocarcinoma
by: Benjamin Stubbe, et al.
Published: (2025-05-01)

HOXA9 and CD163 potentiate pancreatic ductal adenocarcinoma progression
by: Aiat Shaban Hemida, et al.
Published: (2024-10-01)

The scRNA-sequencing landscape of pancreatic ductal adenocarcinoma revealed distinct cell populations associated with tumor initiation and progression
by: Ying Wang, et al.
Published: (2025-05-01)

Diagnostic and therapeutic recommendations in pancreatic ductal adenocarcinoma. Recommendations of the Working Group of the Polish Pancreatic Club
by: Katarzyna Winter, et al.
Published: (2019-03-01)

Clinical application of combined CT radiomics and clinical features in survival prediction for pancreatic ductal adenocarcinoma patients
by: LI Ke, et al.
Published: (2025-07-01)

A radiomics-based model for predicting lymph nodes metastasis of pancreatic ductal adenocarcinoma: a multicenter study
by: Liwen Zhu, et al.
Published: (2025-06-01)

Long-term survival with repeat resection for lung oligometastasis from pancreatic ductal adenocarcinoma: a case report
by: Ryota Matsuki, et al.
Published: (2018-03-01)

Contrast-enhanced MRI-based intratumoral heterogeneity assessment for predicting lymph node metastasis in resectable pancreatic ductal adenocarcinoma
by: Junjian Shen, et al.
Published: (2025-03-01)

Combination of imaging features on pancreatic CT for predicting early recurrence after upfront pancreatoduodenectomy of pancreatic ductal adenocarcinoma
by: Shuanglin Zhang, et al.
Published: (2025-12-01)

Preoperative MRI and CA19-9 for predicting occult lymph node metastasis in small pancreatic ductal adenocarcinoma (≤ 2 cm)
by: Qiying Tang, et al.
Published: (2025-08-01)

Nanocarriers for Combination Therapy in Pancreatic Ductal Adenocarcinoma: A Comprehensive Review
by: Iris Pontón, et al.
Published: (2025-07-01)

Consensus statement on the use of systemic therapies in pancreatic ductal adenocarcinoma in Asia
by: D.-Y. Oh, et al.
Published: (2025-06-01)

Neoadjuvant Stereotactic Ablative Radiotherapy in Pancreatic Ductal Adenocarcinoma: A Review of Perioperative and Long-Term Outcomes
by: Robert Michael O’Connell, et al.
Published: (2025-07-01)

Clinical Implications of Mismatch Repair Deficiency in Pancreatic Ductal Adenocarcinoma
by: Zachary Kaplan, et al.
Published: (2025-05-01)

The Clonal Trajectory of Liver and Lung Metastases in Pancreatic Ductal Adenocarcinoma
by: Ofer N. Gofrit, et al.
Published: (2025-05-01)

Peripheral Eosinophil Count May Be the Prognostic Factor for Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Treatment
by: Wojciech Ciesielski, et al.
Published: (2024-11-01)

Pancreatic ductal adenocarcinoma with inferior vena cava invasion: a report of three resected cases
by: Takuya Mizumoto, et al.
Published: (2017-05-01)

Successful resection of port site recurrence of pancreatic ductal adenocarcinoma after laparoscopic distal pancreatectomy
by: Takashi Aida, et al.
Published: (2023-03-01)

Molecular analysis highlights TREM2 as a discriminating biomarker for patients suffering from pancreatic ductal adenocarcinoma
by: Dimitrios Papakonstantinou, et al.
Published: (2025-01-01)

A scoring model for preoperative differentiation of high-enhancement pancreatic ductal adenocarcinoma from mass-forming chronic pancreatitis
by: Jiaping Zhou, et al.
Published: (2025-07-01)

Differentiating localized autoimmune pancreatitis and pancreatic ductal adenocarcinoma using endoscopic ultrasound images with deep learning
by: Hitomi Nakamura, et al.
Published: (2024-04-01)

A 3D Bio-Printed-Based Model for Pancreatic Ductal Adenocarcinoma
by: Claire Godier, et al.
Published: (2024-09-01)

Targeting FGFR4 abrogates HNF1A-driven metastasis in pancreatic ductal adenocarcinoma
by: Katherine J. Crawford, et al.
Published: (2025-07-01)

Gene Expression Profiling of Pancreatic Ductal Adenocarcinoma Arising From Intraductal Papillary Mucinous Neoplasms of the Pancreas
by: William A. Ziaziaris, et al.
Published: (2024-12-01)

Identification of SMAD4-mutated pancreatic ductal adenocarcinoma using preoperative contrast-enhanced MRI and clinical characteristics
by: Zhina Li, et al.
Published: (2024-12-01)

Lactate-related lncRNAs assessment model predicts the prognosis of pancreatic ductal adenocarcinoma
by: Jing Sun, et al.
Published: (2025-07-01)

Comprehensive analysis of SQOR involvement in ferroptosis resistance of pancreatic ductal adenocarcinoma in hypoxic environments
by: Quan Lin, et al.
Published: (2025-05-01)

Blood-based biomarkers in pancreatic ductal adenocarcinoma: developments over the last decade and what holds for the future- a review
by: Ronit Juthani, et al.
Published: (2025-04-01)

Precise stratification of prognosis in pancreatic ductal adenocarcinoma patients based on pre- and postoperative genomic information
by: Kokichi Miyamoto, et al.
Published: (2025-08-01)

Identification and validation of a novel autoantibody biomarker panel for differential diagnosis of pancreatic ductal adenocarcinoma
by: Metoboroghene O. Mowoe, et al.
Published: (2025-01-01)

Proteomic insights into early pancreatic ductal adenocarcinoma biology and screening
by: Yue Huang, et al.
Published: (2025-08-01)

Oncological Outcomes of Open Versus Minimally Invasive Surgery for Ductal Adenocarcinomas of Pancreatic Head: A Propensity Score Matching Analysis
by: Alessandro Giani, et al.
Published: (2024-10-01)